These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9755839)

  • 21. Tumour necrosis factor-alpha and soluble Fas ligand as biomarkers in non-acetaminophen-induced acute liver failure.
    Singhal S; Chakravarty A; Das BC; Kar P
    Biomarkers; 2009 Aug; 14(5):347-53. PubMed ID: 19505222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis.
    Nagaki M; Iwai H; Naiki T; Ohnishi H; Muto Y; Moriwaki H
    J Infect Dis; 2000 Oct; 182(4):1103-8. PubMed ID: 10979906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma.
    Nada O; Abdel-Hamid M; Ismail A; El Shabrawy L; Sidhom KF; El Badawy NM; Ghazal FA; El Daly M; El Kafrawy S; Esmat G; Loffredo CA
    J Clin Virol; 2005 Oct; 34(2):140-6. PubMed ID: 16157266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum analyte pattern characteristic of fulminant hepatic failure.
    Sunheimer R; Capaldo G; Kashanian F; Finck C; Woo J; Korins M; Huang SG; Winters L; Spitz D; Rieger I
    Ann Clin Lab Sci; 1994; 24(2):101-9. PubMed ID: 8203819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased circulating Fas ligand in patients with familial combined hyperlipidemia or carotid atherosclerosis: normalization by atorvastatin.
    Blanco-Colio LM; Martín-Ventura JL; Sol JM; Díaz C; Hernández G; Egido J
    J Am Coll Cardiol; 2004 Apr; 43(7):1188-94. PubMed ID: 15063428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Soluble tumor necrosis factor related apoptosis inducing ligand (sTRAIL) and clinical outcome of HBV infection in human].
    Yue FE; Liu DY; Song J; Zhang LN
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):146-8. PubMed ID: 16027782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased serum soluble Fas in patients with acute liver failure due to paracetamol overdose.
    Tagami A; Ohnishi H; Hughes RD
    Hepatogastroenterology; 2003; 50(51):742-5. PubMed ID: 12828076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of soluble molecules associated with evasion of immune surveillance: a study in biliary disease.
    Enjoji M; Yamaguchi K; Nakashima M; Ohta S; Kotoh K; Fukushima M; Kuniyoshi M; Tanaka M; Nakamuta M; Watanabe T; Nawata H
    Liver Int; 2004 Aug; 24(4):330-4. PubMed ID: 15287856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocyte growth factor (HGF) in patients with hepatitis B and meningitis.
    Ozden M; Kalkan A; Demirdag K; Denk A; Kilic SS
    J Infect; 2004 Oct; 49(3):229-35. PubMed ID: 15337340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The serum glutamic oxaloacetic transaminase/serum glutamic pyruvic transaminase ratio as a prognostic index in severe acute viral hepatitis.
    Gitlin N
    Am J Gastroenterol; 1982 Jan; 77(1):2-4. PubMed ID: 6801971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble Fas and Fas ligand provide new information on metastasis and response to chemotherapy in SCLC patients.
    Shimizu M; Kondo M; Ito Y; Kume H; Suzuki R; Yamaki K
    Cancer Detect Prev; 2005; 29(2):175-80. PubMed ID: 15829378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated serum soluble Fas ligand is a promising marker of testicular toxicity induced by epirubicin in rats.
    Geng J; Fan J; Jiang HW; Fang ZJ; Wang X; Sun JL; Ding Q; Chen G
    Toxicol Lett; 2009 Apr; 186(2):96-103. PubMed ID: 19429229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum hepatocyte growth factor in acute hepatic failure in comparison with acute hepatitis.
    Shiota G; Okano J; Umeki K; Kawasaki H; Kawamoto T; Nakamura T
    Res Commun Mol Pathol Pharmacol; 1994 Aug; 85(2):157-62. PubMed ID: 7994560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The alteration of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo?
    Nagao M; Nakajima Y; Hisanaga M; Kayagaki N; Kanehiro H; Aomatsu Y; Ko S; Yagita H; Yamada T; Okumura K; Nakano H
    Hepatology; 1999 Aug; 30(2):413-21. PubMed ID: 10421649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
    Hoffmann TK; Dworacki G; Tsukihiro T; Meidenbauer N; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of the effect of splenectomy on hepatic functional reserve and structural damage in patients with chronic hepatitis C virus infection by non-invasive serum markers. A prospective study.
    Elsebae MM; Abu-Zekri NB
    Int J Surg; 2008 Oct; 6(5):362-6. PubMed ID: 18662898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the maternal and umbilical vein serum sFas/sFasL system in pregnancies complicated by preeclampsia with intrauterine growth retardation.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):155-9. PubMed ID: 16169656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble form of TRAIL, Fas and FasL in the serum of patients with B-CLL.
    Jabłońska E; Kiersnowska-Rogowska B; Rogowski F; Parfieńczyk A; Puzewska W; Bukin M
    Rocz Akad Med Bialymst; 2005; 50():204-7. PubMed ID: 16358967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
    Tinazzi E; Puccetti A; Gerli R; Rigo A; Migliorini P; Simeoni S; Beri R; Dolcino M; Martinelli N; Corrocher R; Lunardi C
    Int Immunol; 2009 Mar; 21(3):237-43. PubMed ID: 19181929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of a combination of soluble Fas and soluble Fas ligand in the serum of patients with Ta bladder cancer.
    Mizutani Y; Yoshida O; Ukimura O; Kawauchi A; Bonavida B; Miki T
    Cancer Biother Radiopharm; 2002 Oct; 17(5):563-7. PubMed ID: 12470426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.